Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

No BS RX vs NowPatient

By GLP-1 ScorecardUpdated

No BS RXFactor scores not reassessed.
Site position #23

Higher score

NowPatientFactor scores not reassessed.
Site position #237

Lower score

Score comparison

No BS RX has the higher recorded score — 82.8/100 to 65.5/100.

No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.

Before you choose

Before comparing the headline prices, the No BS RX review and the NowPatient review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.

If neither one fits, No BS RX vs Nu Image Medical and NowPatient vs Sesame Care compare each of them with another graded program, and the list of alternatives to No BS RX ranks the programs closest to No BS RX on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNo BS RX +57
92
35
Dose & formulationNowPatient +3
90
93
Clinical oversightNowPatient +14
72
86
Labs & monitoringNo BS RX +14
68
54
FulfillmentNo BS RX +24
94
70
Contract termsNo BS RX +19
74
55
No BS RX · top barNowPatient · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNo BS RXNowPatient
WeighScore82.8/10065.5/100
GradeB−C
Site position#23#237
Semaglutide$149/mo advertised for standard compounded injection; low-dose priced separatelyBrand Wegovy $215.98-$395.98 per pen by strength, plus $75 shipping and import duties
Tirzepatide$225/mo advertised for standard compounded injection; low-dose priced separatelyBrand Mounjaro $251.98-$476.98 per pen by strength, plus $75 shipping and import duties
CoverageConfirm program availability for your stateCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
No BS RX

Site position #23 · B−

Factor scores not reassessed.

Strengths

  • Displays monthly and prepaid amounts by program
  • Advertises consultation, medication, shipping and messaging in the compounded plans
  • Lists branded Ozempic and Zepbound separately

What to consider

  • The $115 headline applies to low-dose programs
  • Plans renew automatically at the then-current rate
  • Cancellation generally stops future billing without refunding the current period
NowPatient

Site position #237 · C

Factor scores not reassessed.

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

What to consider

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard